These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20452372)

  • 1. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China.
    Yin X; Yu Z
    J Infect; 2010 Jul; 61(2):150-4. PubMed ID: 20452372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.
    Shi R; Zhang J; Li C; Kazumi Y; Sugawara I
    J Clin Microbiol; 2006 Dec; 44(12):4566-8. PubMed ID: 17035499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
    Long Q; Li W; Du Q; Fu Y; Liang Q; Huang H; Xie J
    Int J Antimicrob Agents; 2012 Jun; 39(6):486-9. PubMed ID: 22526012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
    Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
    Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
    Pitaksajjakul P; Wongwit W; Punprasit W; Eampokalap B; Peacock S; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():228-37. PubMed ID: 16438215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
    Pitaksajjakul P; Worakhunpiset S; Chaiprasert A; Boonyasopun J; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1163-7. PubMed ID: 22299442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital.
    Soudani A; Hadjfredj S; Zribi M; Messaoud T; Masmoudi A; Majed B; Fendri C
    Clin Microbiol Infect; 2010 Sep; 16(9):1454-7. PubMed ID: 19845696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
    Gui J; Wang F; Luo DQ; Wang HF; Peng Y; Zhang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):276-9. PubMed ID: 20646459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
    Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
    Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
    Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Bernard C; Veziris N; Brossier F; Sougakoff W; Jarlier V; Robert J; Aubry A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1519-24. PubMed ID: 25534742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based investigation of fluoroquinolones resistant tuberculosis in rural eastern China.
    Hu Y; Mathema B; Wang W; Kreiswirth B; Jiang W; Xu B
    Tuberculosis (Edinb); 2011 May; 91(3):238-43. PubMed ID: 21450523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
    Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
    PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.